Cure My Disease

Don't miss your cure!

 Log in / Sign up

Peer power: mentors help young diabetics navigate adult care

NCT ID NCT04247620

Disease control Sponsor: Baylor College of Medicine Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether trained peer mentors (ages 20-35) could help young adults (ages 17-25) with type 1 diabetes better control their blood sugar and smoothly move from pediatric to adult diabetes care. 144 participants were randomly assigned to receive peer support or usual care. The main goal was to see if blood sugar levels improved after 12 months. This is a disease management study, not a cure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 2

Tests whether the treatment actually works, and watches for side effects, in a larger group.

Participants

144 people

The number who actually took part.

Started

Dec 2020

Finished

Sep 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

17 to 35 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Young Adult Inclusion/Exclusion Criteria Inclusion Criteria: * has a diagnosis of type 1 diabetes of at least 1 year * currently receiving care at a Texas Children's Hospital Diabetes Care Center location * is between the ages of 17-25 years at enrollment * exhibits fluency in reading/speaking English * their endocrine provider confirmed plans to transfer to adult provider in the next 6 months Exclusion Criteria: * serious medical, cognitive, or mental health comorbidity that would preclude ability to provide informed consent or participate in data collection or intervention Peer Mentor Inclusion/Exclusion Criteria Inclusion Criteria: * was diagnosed with type 1 diabetes before age 18 * has a diagnosis of type 1 diabetes of at least 1 years * is between the ages of 20-35 at enrollment * has been previously treated in pediatric care and is currently treated in adult care * demonstrated interest and ability to effectively deliver the peer intervention \& * exhibits fluency in reading/speaking English Exclusion Criteria: * serious medical, cognitive, or mental health comorbidity that would preclude ability to fulfill role or complete questionnaires.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Type 1 diabetes are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Type 1 diabetes

Contacts and locations

Locations

  • Baylor College of Medicine

    Houston, Texas, 77030, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.